retatrutide weight loss clinical trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide Weight Loss Results:Trial Data
Description
For someone new to incretin-based therapies with 40-50 lbs to lose, Tirzepatide offers an excellent starting point with proven results and established protocols

Benny sees it as a way to help me worry less and bother him less, which is fair

This is considered the standard ratio because it makes the math very straightforward

FDA approved
However, theres an important caveat: 5-HTP affects serotonin levels, so it can interact with medications that also affect serotonin (such as SSRIs and MAOIs)

Patients with active inflammation, recent flares, severe malnutrition, strictures, or unstable medication regimens should generally avoid GLP-1 initiation until disease control improves
